List of Tables
    Table 1. Neuroprotective Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Neuroprotective Drugs Market Trends
    Table 3. Neuroprotective Drugs Market Drivers
    Table 4. Neuroprotective Drugs Market Challenges
    Table 5. Neuroprotective Drugs Market Restraints
    Table 6. Global Neuroprotective Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Neuroprotective Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Neuroprotective Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Neuroprotective Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Neuroprotective Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Neuroprotective Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Neuroprotective Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Neuroprotective Drugs Sales by Manufacturer, (MT), 2017-2022
    Table 14. Global Neuroprotective Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Neuroprotective Drugs Price by Manufacturer (2017-2022) & (USD/Kg)
    Table 16. Global Neuroprotective Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Neuroprotective Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroprotective Drugs as of 2021)
    Table 18. Top Players of Neuroprotective Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Neuroprotective Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Neuroprotective Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Neuroprotective Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Neuroprotective Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Neuroprotective Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Neuroprotective Drugs Sales by Players, (MT), 2020, 2021 & 2022
    Table 26. United States Neuroprotective Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Neuroprotective Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Neuroprotective Drugs Sales in Volume by Region (2017-2022) & (MT)
    Table 29. Global Neuroprotective Drugs Sales in Volume Forecast by Region (2023-2028) & (MT)
    Table 30. Global Neuroprotective Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Neuroprotective Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Neuroprotective Drugs Sales in Volume by Country (2017-2028) & (MT)
    Table 33. North America Neuroprotective Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Neuroprotective Drugs Sales in Volume by Region (2017-2028) & (MT)
    Table 35. Asia Pacific Neuroprotective Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Neuroprotective Drugs Sales in Volume by Country (2017-2028) & (MT)
    Table 37. Europe Neuroprotective Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Neuroprotective Drugs Sales in Volume by Country (2017-2028) & (MT)
    Table 39. Latin Americaa Neuroprotective Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Neuroprotective Drugs Sales in Volume by Country (2017-2028) & (MT)
    Table 41. Middle East and Africa Neuroprotective Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Genervon Corporation Information
    Table 43. Genervon Description and Business Overview
    Table 44. Genervon Neuroprotective Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 45. Genervon Neuroprotective Drugs Product
    Table 46. Genervon Recent Development
    Table 47. NeuroVive Pharmaceutical Corporation Information
    Table 48. NeuroVive Pharmaceutical Description and Business Overview
    Table 49. NeuroVive Pharmaceutical Neuroprotective Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 50. NeuroVive Pharmaceutical Product
    Table 51. NeuroVive Pharmaceutical Recent Development
    Table 52. Ceregene Corporation Information
    Table 53. Ceregene Description and Business Overview
    Table 54. Ceregene Neuroprotective Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 55. Ceregene Product
    Table 56. Ceregene Recent Development
    Table 57. BHR Pharma Corporation Information
    Table 58. BHR Pharma Description and Business Overview
    Table 59. BHR Pharma Neuroprotective Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 60. BHR Pharma Product
    Table 61. BHR Pharma Recent Development
    Table 62. Neuren Pharmaceuticals Corporation Information
    Table 63. Neuren Pharmaceuticals Description and Business Overview
    Table 64. Neuren Pharmaceuticals Neuroprotective Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 65. Neuren Pharmaceuticals Product
    Table 66. Neuren Pharmaceuticals Recent Development
    Table 67. Allon therapeutics Corporation Information
    Table 68. Allon therapeutics Description and Business Overview
    Table 69. Allon therapeutics Neuroprotective Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 70. Allon therapeutics Product
    Table 71. Allon therapeutics Recent Development
    Table 72. Bionure Corporation Information
    Table 73. Bionure Description and Business Overview
    Table 74. Bionure Neuroprotective Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 75. Bionure Product
    Table 76. Bionure Recent Development
    Table 77. Key Raw Materials Lists
    Table 78. Raw Materials Key Suppliers Lists
    Table 79. Neuroprotective Drugs Customers List
    Table 80. Neuroprotective Drugs Distributors List
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Neuroprotective Drugs Product Picture
    Figure 2. Global Neuroprotective Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Neuroprotective Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Neuroprotective Drugs Sales 2017-2028 (MT)
    Figure 5. United States Neuroprotective Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Neuroprotective Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Neuroprotective Drugs Sales 2017-2028 (MT)
    Figure 8. United States Neuroprotective Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Neuroprotective Drugs Market Share in Global, in Volume (MT) 2017-2028
    Figure 10. Neuroprotective Drugs Report Years Considered
    Figure 11. Product Picture of Cholinesterase inhibitors
    Figure 12. Product Picture of Anti-inflammatory
    Figure 13. Product Picture of Others
    Figure 14. Global Neuroprotective Drugs Market Share by Type in 2022 & 2028
    Figure 15. Global Neuroprotective Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Neuroprotective Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Neuroprotective Drugs Sales by Type (2017-2028) & (MT)
    Figure 18. Global Neuroprotective Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Neuroprotective Drugs Price by Type (2017-2028) & (USD/Kg)
    Figure 20. United States Neuroprotective Drugs Market Share by Type in 2022 & 2028
    Figure 21. United States Neuroprotective Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Neuroprotective Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Neuroprotective Drugs Sales by Type (2017-2028) & (MT)
    Figure 24. United States Neuroprotective Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Neuroprotective Drugs Price by Type (2017-2028) & (USD/Kg)
    Figure 26. Product Picture of Alzheimer's disease
    Figure 27. Product Picture of Parkinson's disease
    Figure 28. Product Picture of Others
    Figure 29. Global Neuroprotective Drugs Market Share by Application in 2022 & 2028
    Figure 30. Global Neuroprotective Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Neuroprotective Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Neuroprotective Drugs Sales by Application (2017-2028) & (MT)
    Figure 33. Global Neuroprotective Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Neuroprotective Drugs Price by Application (2017-2028) & (USD/Kg)
    Figure 35. United States Neuroprotective Drugs Market Share by Application in 2022 & 2028
    Figure 36. United States Neuroprotective Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Neuroprotective Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Neuroprotective Drugs Sales by Application (2017-2028) & (MT)
    Figure 39. United States Neuroprotective Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Neuroprotective Drugs Price by Application (2017-2028) & (USD/Kg)
    Figure 41. North America Neuroprotective Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 42. North America Neuroprotective Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Neuroprotective Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 46. Europe Neuroprotective Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Neuroprotective Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 53. Asia-Pacific Neuroprotective Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Neuroprotective Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 65. Latin America Neuroprotective Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Neuroprotective Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 70. Middle East & Africa Neuroprotective Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Neuroprotective Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Neuroprotective Drugs Value Chain
    Figure 75. Neuroprotective Drugs Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed